Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial
Authors:
- 25 May 2012
- journal article
- research article
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 44 (06) , 584-589
Abstract
Background and study aims: Endoscopic submucosal dissection (ESD) has become a standard treatment. However, the treatment time tends to be relatively long and insufflation and manipulation of the endoscope can increase pain and discomfort. We aimed to find an optimal method for sedation during ESD. Patients and methods: Patients scheduled to undergo ESD for early gastric cancer or adenoma were randomly assigned to sedation with midazolam or propofol, and consciousness level was evaluated by bispectral index (BIS) monitoring. Primary end points of effectiveness (three parameters) and secondary end points of safety during ESD and after return to the ward were compared between the groups. Study registration was in the UMIN Clinical Trial Registry (UMIN 000001497), and the institutional trial number was KDOG 0801. Results: From June 2008 through June 2009, we enrolled 178 patients (90 midazolam, 88 propofol). Regarding safety after ESD, recovery was significantly better in the propofol group immediately after and at 1 hour and 2 hours after return to the ward (P < 0.001). The number of patients who required a continuous supply of oxygen 2 hours after returning to the ward was significantly lower in the propofol group (midazolam 18; propofol 6; P = 0.010). Though propofol seemed to be better for effectiveness and safety, there were no statistically significant differences for all three primary end points and the safety parameters (hypotension, hypoxia, bradycardia). Conclusions: Propofol with BIS monitoring improved recovery of patients after ESD, though this study was underpowered to prove the effectiveness and safety of propofol.Keywords
This publication has 13 references indexed in Scilit:
- European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopyEndoscopy, 2010
- Extended Monitoring of the Sedated Patient: Bispectral Index, Narcotrend® and Automated Responsiveness MonitorDigestion, 2010
- Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteriaBritish Journal of Surgery, 2010
- Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injectionJournal of Gastroenterology, 2010
- Position statement: nonanesthesiologist administration of propofol for GI endoscopyGastrointestinal Endoscopy, 2009
- Midazolam and pethidine versus propofol and fentanyl patient controlled sedation/analgesia for upper gastrointestinal tract ultrasound endoscopy: A prospective randomized controlled trialDigestive and Liver Disease, 2007
- Prospective randomized trial evaluating ketamine for advanced endoscopic procedures in difficult to sedate patientsAlimentary Pharmacology & Therapeutics, 2007
- Propofol Sedation during Endoscopic Procedures: Safe and Effective Administration by Registered Nurses Supervised by EndoscopistsEndoscopy, 2006
- Deep Sedation Occurs Frequently During Elective Endoscopy with Meperidine and MidazolamAmerican Journal of Gastroenterology, 2005
- Sedation with Propofol for Routine ERCP in High-Risk Octogenarians: A Randomized, Controlled StudyAmerican Journal of Gastroenterology, 2005